Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes

OBJECTIVE: In patients with long-standing type 1 diabetes, we investigated whether improved β-cell function can be achieved by combining intensive insulin therapy with agents that may 1) promote β-cell growth and/or limit β-cell apoptosis and 2) weaken the anti–β-cell autoimmunity. RESEARCH DESIGN A...

Descripción completa

Detalles Bibliográficos
Autores principales: Rother, Kristina I., Spain, Lisa M., Wesley, Robert A., Digon, Benigno J., Baron, Alain, Chen, Kim, Nelson, Patric, Dosch, H.-Michael, Palmer, Jerry P., Brooks-Worrell, Barbara, Ring, Michael, Harlan, David M.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782986/
https://www.ncbi.nlm.nih.gov/pubmed/19808924
http://dx.doi.org/10.2337/dc09-0773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782986/
https://www.ncbi.nlm.nih.gov/pubmed/19808924
http://dx.doi.org/10.2337/dc09-0773

Ejemplares similares